SCHEMBL7736141

SCHEMBL7736141

Nc1nc2ccc(C(=O)C(CNS(=O)(=O)c3ccccc3)N3CCC(Cc4ccccc4)CC3)cc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
CYP2D6 P10635 4/20 0.45
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 1/20 0.44
MAPK1 P28482 1/20 0.43
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP3A4 P08684 4/20 0.40
CYP1A2 P05177 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7731064 0.91 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7723256 0.86 CYP2C9 (0.55) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7736257 0.83 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7733873 0.82 CYP2D6 (0.41) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7733096 0.82 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7734109 0.81 GRIN2B (0.54) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7732672 0.75 ACHE (0.64) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL8117602 0.75 CYP2D6 (0.41) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7732684 0.74 GRIN2B (0.40) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL7732339 0.72 CYP2C9 (0.49) ALDH1A1MEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407122-B1 NEUROPROTECTIVE AGENTS, ANTIISCHEMIC, AND HYPERGLYCEMIC AGENTS; HUNTINGTON*S, PARKINSON*S, AND ALZHEIMER*S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS TREATMENT; NERVOUS SYSTEM AND BRAIN DISORDERS PHARMACIA & UPJOHN S.P.A. (IT) 2002-06-18 US disclosed